Search

everythinglearnresearchcommunity

for

Search:↓

Frontal Fibrosing Alopecia is a poorly understood condition that is hard to treat and causes distressing hair loss.

Curcumin applied to the skin can start hair growth in mice.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

Stem cells could improve hair growth and new treatments for baldness are being researched.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

Leflunomide is more likely to help treat alopecia areata than cause it.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Early genetic testing and JAK inhibitors can help treat systemic inflammation in SAVI patients.

Pediatric dermatologists have varied preferences for treating alopecia areata in children, with no standard FDA-approved treatments and some using JAK inhibitors despite risks.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

Baricitinib is a new, effective treatment for advanced alopecia areata but is costly and has risks.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

The document discusses hair and nail conditions, updates on treatments for alopecia, and controversies around finasteride use.

Different scalp and hair disorders are more common in certain ethnic groups, with the most common being androgenetic alopecia, which is treated with medications like minoxidil and finasteride.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

iNOS contributes to hair loss in obese diabetic mice and blocking it may encourage hair growth.

A patient's hair loss may be linked to their diabetes medication, Sitagliptin.

Lithocholic acid helps hair growth and regeneration in alopecia by activating vitamin D receptors.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

A woman with a type of hair loss saw hair regrowth after two months of taking baricitinib.